DocuSign, Inc. (NASDAQ:DOCU – Get Free Report) insider James P. Shaughnessy sold 7,500 shares of DocuSign stock in a transaction that occurred on Tuesday, April 1st. The shares were sold at an average price of $81.31, for a total value of $609,825.00. Following the sale, the insider now directly owns 45,875 shares in the company, valued at $3,730,096.25. The trade was a 14.05 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at this link.
DocuSign Stock Performance
DOCU opened at $72.21 on Friday. The company has a fifty day moving average price of $86.02 and a two-hundred day moving average price of $81.98. The firm has a market capitalization of $14.62 billion, a PE ratio of 14.89, a P/E/G ratio of 6.94 and a beta of 1.20. DocuSign, Inc. has a 52 week low of $48.70 and a 52 week high of $107.86.
DocuSign (NASDAQ:DOCU – Get Free Report) last issued its earnings results on Thursday, March 13th. The company reported $0.86 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.84 by $0.02. The firm had revenue of $776.25 million for the quarter, compared to analysts’ expectations of $760.94 million. DocuSign had a return on equity of 14.90% and a net margin of 34.73%. The company’s revenue was up 9.0% compared to the same quarter last year. During the same quarter last year, the business earned $0.76 earnings per share. Equities analysts forecast that DocuSign, Inc. will post 1.17 EPS for the current year.
Hedge Funds Weigh In On DocuSign
Wall Street Analyst Weigh In
Several brokerages recently commented on DOCU. Hsbc Global Res raised DocuSign to a “moderate sell” rating in a research note on Friday, December 6th. JMP Securities reiterated a “market outperform” rating and set a $124.00 target price on shares of DocuSign in a research report on Tuesday, January 7th. Morgan Stanley boosted their price target on shares of DocuSign from $62.00 to $97.00 and gave the company an “equal weight” rating in a research report on Friday, December 6th. UBS Group cut their target price on shares of DocuSign from $100.00 to $90.00 and set a “neutral” rating for the company in a research note on Friday, March 14th. Finally, Royal Bank of Canada reaffirmed a “sector perform” rating and set a $90.00 price target on shares of DocuSign in a report on Friday, March 14th. Two analysts have rated the stock with a sell rating, nine have given a hold rating and four have assigned a buy rating to the stock. According to data from MarketBeat, the stock currently has a consensus rating of “Hold” and a consensus target price of $95.83.
Read Our Latest Stock Report on DocuSign
DocuSign Company Profile
DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.
Further Reading
- Five stocks we like better than DocuSign
- EV Stocks and How to Profit from Them
- Archer Aviation’s Africa Deal Could Boost ACHR Stock
- How to Effectively Use the MarketBeat Ratings Screener
- Are Short Sellers Wrong About These 3 Semiconductor Stocks?
- What Are Dividend Contenders? Investing in Dividend Contenders
- Boeing Gets $50B in March Orders—Is BA Stock a Buy Now?
Receive News & Ratings for DocuSign Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DocuSign and related companies with MarketBeat.com's FREE daily email newsletter.